Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
Open Access
- 1 February 2019
- journal article
- research article
- Published by Elsevier BV in Lancet
- Vol. 393 (10170), 423-433
- https://doi.org/10.1016/S0140-6736(18)32221-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Role of Innate Immunity in Neonatal InfectionAmerican Journal of Perinatology, 2013
- Bovine Lactoferrin Supplementation for Prevention of Late-Onset Sepsis in Very Low-Birth-Weight NeonatesA Randomized TrialPublished by American Medical Association (AMA) ,2009
- Using a Count of Neonatal Morbidities to Predict Poor Outcome in Extremely Low Birth Weight Infants: Added Role of Neonatal InfectionPediatrics, 2009
- A case definition for national and international neonatal bloodstream infection surveillanceArchives of Disease in Childhood: Fetal & Neonatal, 2008
- Why Most Discovered True Associations Are InflatedEpidemiology, 2008
- Sub-chronic (13-week) oral toxicity study in rats with recombinant human lactoferrin produced in the milk of transgenic cowsFood and Chemical Toxicology, 2006
- Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary DysplasiaPediatrics, 2005
- Lactoferrin in the Preterm Infants' Diet Attenuates Iron-Induced Oxidation ProductsPediatric Research, 2002
- Lactoferrin in the Preterm Infants' Diet Attenuates Iron-Induced Oxidation ProductsPediatric Research, 2002
- Lactoferricin of Bovine Origin is More Active than Lactoferricins of Human, Murine and Caprine OriginScandinavian Journal of Infectious Diseases, 1998